CD274 and neoplasm: IH associated with OSA promotes the expression of PD-L1 in tumor cells, and by blocking the binding between PD-1 and PD-L1, PD-1/PD-L1 inhibitors enable immune cells to maintain their activity and restore their recognition and killing of tumor cells.